BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1585 related articles for article (PubMed ID: 33523115)

  • 1. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.
    Ouldali N; Toubiana J; Antona D; Javouhey E; Madhi F; Lorrot M; Léger PL; Galeotti C; Claude C; Wiedemann A; Lachaume N; Ovaert C; Dumortier M; Kahn JE; Mandelcwajg A; Percheron L; Biot B; Bordet J; Girardin ML; Yang DD; Grimaud M; Oualha M; Allali S; Bajolle F; Beyler C; Meinzer U; Levy M; Paulet AM; Levy C; Cohen R; Belot A; Angoulvant F;
    JAMA; 2021 Mar; 325(9):855-864. PubMed ID: 33523115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.
    Son MBF; Murray N; Friedman K; Young CC; Newhams MM; Feldstein LR; Loftis LL; Tarquinio KM; Singh AR; Heidemann SM; Soma VL; Riggs BJ; Fitzgerald JC; Kong M; Doymaz S; Giuliano JS; Keenaghan MA; Hume JR; Hobbs CV; Schuster JE; Clouser KN; Hall MW; Smith LS; Horwitz SM; Schwartz SP; Irby K; Bradford TT; Maddux AB; Babbitt CJ; Rowan CM; McLaughlin GE; Yager PH; Maamari M; Mack EH; Carroll CL; Montgomery VL; Halasa NB; Cvijanovich NZ; Coates BM; Rose CE; Newburger JW; Patel MM; Randolph AG;
    N Engl J Med; 2021 Jul; 385(1):23-34. PubMed ID: 34133855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Multisystem Inflammatory Syndrome in Children.
    McArdle AJ; Vito O; Patel H; Seaby EG; Shah P; Wilson C; Broderick C; Nijman R; Tremoulet AH; Munblit D; Ulloa-Gutierrez R; Carter MJ; De T; Hoggart C; Whittaker E; Herberg JA; Kaforou M; Cunnington AJ; Levin M;
    N Engl J Med; 2021 Jul; 385(1):11-22. PubMed ID: 34133854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective comparative analysis of factors affecting the decision and outcome of initial intravenous immunoglobulin alone or intravenous immunoglobulin plus methylprednisolone use in children with the multisystem inflammatory syndrome.
    Devrim İ; Böncüoğlu E; Kıymet E; Şahinkaya Ş; Çelebi MY; Cem E; Düzgöl M; Arıkan KÖ; Kara AA; Besin D; Vuran G; Seven P; Meşe T; Ağın H; Bayram N
    Pediatr Rheumatol Online J; 2022 Aug; 20(1):69. PubMed ID: 35987681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term Outcomes of Corticosteroid Monotherapy in Multisystem Inflammatory Syndrome in Children.
    Villacis-Nunez DS; Jones K; Jabbar A; Fan L; Moore W; Peter AS; Henderson M; Xiang Y; Kelleman MS; Sherry W; Chandrakasan S; Oster ME; Jaggi P; Prahalad S
    JAMA Pediatr; 2022 Jun; 176(6):576-584. PubMed ID: 35344042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Experience: Corticosteroids as a First-line Therapy in Children With Multisystem Inflammatory Syndrome and COVID-19-related Myocardial Damage.
    Vukomanovic V; Krasic S; Prijic S; Ninic S; Popovic S; Petrovic G; Ristic S; Simic R; Cerovic I; Nesic D
    Pediatr Infect Dis J; 2021 Nov; 40(11):e390-e394. PubMed ID: 34260481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19: A retrospective cohort analysis from 28 U.S. Hospitals.
    Harthan AA; Nadiger M; McGarvey JS; Hanson K; Gharpure VP; Bjornstad EC; Chiotos K; Miller AS; Reikoff RA; Gajic O; Kumar V; Walkey AJ; Kashyap R; Tripathi S;
    Pharmacotherapy; 2022 Jul; 42(7):529-539. PubMed ID: 35661394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.
    Feldstein LR; Tenforde MW; Friedman KG; Newhams M; Rose EB; Dapul H; Soma VL; Maddux AB; Mourani PM; Bowens C; Maamari M; Hall MW; Riggs BJ; Giuliano JS; Singh AR; Li S; Kong M; Schuster JE; McLaughlin GE; Schwartz SP; Walker TC; Loftis LL; Hobbs CV; Halasa NB; Doymaz S; Babbitt CJ; Hume JR; Gertz SJ; Irby K; Clouser KN; Cvijanovich NZ; Bradford TT; Smith LS; Heidemann SM; Zackai SP; Wellnitz K; Nofziger RA; Horwitz SM; Carroll RW; Rowan CM; Tarquinio KM; Mack EH; Fitzgerald JC; Coates BM; Jackson AM; Young CC; Son MBF; Patel MM; Newburger JW; Randolph AG;
    JAMA; 2021 Mar; 325(11):1074-1087. PubMed ID: 33625505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.
    RECOVERY Collaborative Group
    Lancet Child Adolesc Health; 2024 Mar; 8(3):190-200. PubMed ID: 38272046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome.
    Pereira MFB; Litvinov N; Farhat SCL; Eisencraft AP; Gibelli MABC; Carvalho WB; Fernandes VR; Fink TT; Framil JVS; Galleti KV; Fante AL; Fonseca MFM; Watanabe A; Paula CSY; Palandri GG; Leal GN; Diniz MFR; Pinho JRR; Silva CA; Marques HHS; ; Rossi Junior A; Delgado AF; Andrade APM; Schvartsman C; Sabino EC; Rocha MC; Kanunfre KA; Okay TS; Carneiro-Sampaio MMS; Jorge PPD
    Clinics (Sao Paulo); 2020; 75():e2209. PubMed ID: 32844958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory Therapy for MIS-C.
    Ouldali N; Son MBF; McArdle AJ; Vito O; Vaugon E; Belot A; Leblanc C; Murray NL; Patel MM; Levin M; Randolph AG; Angoulvant F;
    Pediatrics; 2023 Jul; 152(1):. PubMed ID: 37376963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Profile and Short-Term Outcome of Children With SARS-CoV-2 Related Multisystem Inflammatory Syndrome (MIS-C) Treated With Pulse Methylprednisolone.
    Sugunan S; Bindusha S; Geetha S; Niyas HR; Kumar AS
    Indian Pediatr; 2021 Aug; 58(8):718-722. PubMed ID: 33876782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical analysis of 11 cases multisystem inflammatory syndrome associated with SARS-CoV-2 Omicron variant infection in children].
    Zhang HS; Chang XT; Wu PH; Song DY; Ge G; Ding W; Hu ZW; Wang GF; Jiang YW; Ye LP
    Zhonghua Er Ke Za Zhi; 2024 Jan; 62(1):55-59. PubMed ID: 38154978
    [No Abstract]   [Full Text] [Related]  

  • 14. Initial Immunomodulation and Outcome of Children with Multisystem Inflammatory Syndrome Related to COVID-19: A Multisite Study from India.
    Bagri NK; Khan M; Pandey RM; Lodha R; Kabra SK;
    Indian J Pediatr; 2022 Dec; 89(12):1236-1242. PubMed ID: 35699843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.
    Chen MR; Kuo HC; Lee YJ; Chi H; Li SC; Lee HC; Yang KD
    Front Immunol; 2021; 12():632890. PubMed ID: 33732254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentially effective drugs for the treatment of COVID-19 or MIS-C in children: a systematic review.
    Wang Z; Zhao S; Tang Y; Wang Z; Shi Q; Dang X; Gan L; Peng S; Li W; Zhou Q; Li Q; Mafiana JJ; Cortés RG; Luo Z; Liu E; Chen Y
    Eur J Pediatr; 2022 May; 181(5):2135-2146. PubMed ID: 35192051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical course and short-term health outcomes of multisystem inflammatory syndrome in children in the single pediatric rheumatology center.
    Sözeri B; Çağlayan Ş; Atasayan V; Ulu K; Coşkuner T; Pelin Akbay Ö; Hasbal Akkuş C; Atay G; Salı E; Karacan M; Öner T; Erdoğan S; Demir F
    Postgrad Med; 2021 Nov; 133(8):994-1000. PubMed ID: 34605352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatments for multi-system inflammatory syndrome in children - discharge, fever, and second-line therapies.
    Tagarro A; Domínguez-Rodríguez S; Mesa JM; Epalza C; Grasa C; Iglesias-Bouzas MI; Fernández-Cooke E; Calvo C; Villaverde S; Torres-Fernández D; Méndez-Echevarria A; Leoz I; Fernández-Pascual M; Saavedra-Lozano J; Soto B; Aguilera-Alonso D; Rivière JG; Fumadó V; Martínez-Campos L; Vivanco A; Pilar-Orive FJ; Alcalá P; Ruiz B; López-Machín A; Oltra M; Moraleda C;
    Eur J Pediatr; 2023 Jan; 182(1):461-466. PubMed ID: 36282324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Multi-inflammatory Syndrome in Children Temporally Related to COVID 19-Clinical Course, Laboratory Profile and Outcomes from a North Indian PICU.
    Chattopadhyay A; Saigal Kalra K; Saikia D; Yadav V; Chouksey J; Jajoo M; Sherwal BL
    J Intensive Care Med; 2022 Sep; 37(9):1229-1237. PubMed ID: 35469487
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinico-Laboratory Profile, Intensive Care Needs and Short-Term Outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience during First and Second Waves from North India.
    Angurana SK; Kumar V; Nallasamy K; Kumar MR; Naganur S; Kumar M; Goyal K; Ghosh A; Bansal A; Jayashree M
    J Trop Pediatr; 2022 Aug; 68(5):. PubMed ID: 36048462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 80.